Skip to content
Disclosery

Artia Global Partners LP

Follow

13F filer, CIK 1937964, MIAMI, FL

Artia Global Partners LP reported $541,855,576 across 48 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 66.49% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001937964-26-000008

Period
2026-06-30
Reported value
$542M
Holdings
48
Top 10 weight
66.49%
New
8
Sold out
10

Largest buys vs the previous quarter

SecurityShares changeApprox. value
BTSGadded+463,515$32.3M
ALKSnew+448,964$23.5M
TVTXadded+268,333$15.2M
RVMDadded+60,400$11.3M
GHnew+38,100$5.72M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
LLYexited-38,220-$35.2M
ABVXreduced-84,300-$11.2M
TERNexited-104,800-$5.53M
INSMreduced-39,660-$4.23M
ASNDexited-17,740-$4.06M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001937964-26-000008, largest first. % of portfolio is the value over $526,030,576, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 225,453 shares; 2025Q4: 600,747 shares; 2026Q1: 600,747 shares; 2026Q2: 516,447 shares 516,447$68.8M13.08%-84,300Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 52,939 shares; 2024Q4: 167,939 shares; 2025Q1: 318,239 shares; 2025Q2: 752,712 shares; 2025Q3: 732,212 shares; 2025Q4: 682,212 shares; 2026Q1: 628,712 shares; 2026Q2: 589,052 shares 589,052$62.8M11.94%-39,660Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,311,840 shares; 2025Q3: 1,999,702 shares; 2025Q4: 2,013,602 shares; 2026Q1: 2,013,602 shares; 2026Q2: 2,210,852 shares 2,210,852$41.2M7.84%+197,250Timeline
BTSGBRIGHTSPRING HEALTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 41,600 shares; 2025Q4: 41,600 shares; 2026Q1: 53,800 shares; 2026Q2: 517,315 shares 517,315$36.1M6.86%+463,515Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 95,885 shares; 2024Q4: 284,190 shares; 2025Q1: 104,190 shares; 2025Q2: 104,190 shares; 2025Q3: 104,190 shares; 2025Q4: 104,190 shares; 2026Q1: 124,990 shares; 2026Q2: 185,390 shares 185,390$34.7M6.6%+60,400Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 15,138 shares; 2024Q4: 11,311 shares; 2025Q1: 11,311 shares; 2025Q2: 78,311 shares; 2025Q3: 78,311 shares; 2025Q4: 64,699 shares; 2026Q1: 29,739 shares; 2026Q2: 29,739 shares 29,739$27.6M5.25%0Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 448,964 shares 448,964$23.5M4.47%newTimeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 30,900 shares; 2025Q2: 30,900 shares; 2025Q3: 30,900 shares; 2025Q4: 70,700 shares; 2026Q1: 70,700 shares; 2026Q2: 339,033 shares 339,033$19.3M3.66%+268,333Timeline
AZNASTRAZENECA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 95,376 shares; 2026Q2: 98,376 shares 98,376$18.7M3.55%+3,000Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 54,285 shares; 2024Q4: 54,285 shares; 2025Q1: not reported; 2025Q2: 27,319 shares; 2025Q3: 194,838 shares; 2025Q4: 503,936 shares; 2026Q1: 503,936 shares; 2026Q2: 503,936 shares 503,936$17.1M3.25%0Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 108,723 shares; 2025Q4: 205,090 shares; 2026Q1: 162,990 shares; 2026Q2: 162,990 shares 162,990$15.9M3.02%0Timeline
DGXQUEST DIAGNOSTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 56,717 shares; 2025Q2: 81,717 shares; 2025Q3: 81,717 shares; 2025Q4: 40,817 shares; 2026Q1: 40,817 shares; 2026Q2: 65,122 shares 65,122$13.8M2.62%+24,305Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 30,479 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 60,176 shares; 2025Q4: 144,376 shares; 2026Q1: 144,376 shares; 2026Q2: 144,376 shares 144,376$11.4M2.18%0Timeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 156,300 shares; 2024Q4: 216,700 shares; 2025Q1: 316,700 shares; 2025Q2: 316,700 shares; 2025Q3: 628,367 shares; 2025Q4: 767,098 shares; 2026Q1: 767,098 shares; 2026Q2: 767,098 shares 767,098$11M2.09%0Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 325,046 shares; 2026Q2: 278,546 shares 278,546$7.84M1.49%-46,500Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 532,879 shares; 2024Q4: 90,279 shares; 2025Q1: 90,279 shares; 2025Q2: 96,479 shares; 2025Q3: 146,179 shares; 2025Q4: 719,365 shares; 2026Q1: 180,731 shares; 2026Q2: 180,731 shares 180,731$7.05M1.34%0Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 12,900 shares; 2026Q1: 15,576 shares; 2026Q2: 59,316 shares 59,316$6.21M1.18%+43,740Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 16,300 shares; 2026Q2: 70,700 shares 70,700$6.02M1.14%+54,400Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 46,700 shares; 2026Q2: 46,700 shares 46,700$6M1.14%0Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 64,608 shares; 2025Q4: 138,508 shares; 2026Q1: 138,508 shares; 2026Q2: 138,508 shares 138,508$5.77M1.1%0Timeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 22,600 shares; 2026Q2: 22,600 shares 22,600$5.74M1.09%0Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 38,100 shares 38,100$5.72M1.09%newTimeline
ABSIABSCI CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 464,444 shares 464,444$5.38M1.02%newTimeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 172,185 shares; 2025Q2: 126,285 shares; 2025Q3: 96,285 shares; 2025Q4: 96,285 shares; 2026Q1: 96,285 shares; 2026Q2: 96,285 shares 96,285$5.3M1.01%0Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 119,741 shares; 2026Q1: 119,741 shares; 2026Q2: 119,741 shares 119,741$5.27M1%0Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 17,740 shares 17,740$4.73M0.9%newTimeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 129,800 shares; 2026Q1: 129,800 shares; 2026Q2: 129,800 shares 129,800$4.59M0.87%0Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,992,367 shares; 2026Q1: 1,992,367 shares; 2026Q2: 1,992,367 shares 1,992,367$4.16M0.79%0Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 65,500 shares; 2026Q2: 98,800 shares 98,800$4.01M0.76%+33,300Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 18,437 shares; 2026Q2: 18,437 shares 18,437$3.98M0.76%0Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 40,000 shares; 2024Q4: 40,000 shares; 2025Q1: 40,000 shares; 2025Q2: 40,000 shares; 2025Q3: 40,000 shares; 2025Q4: 40,000 shares; 2026Q1: 65,000 shares; 2026Q2: 65,000 shares 65,000$3.92M0.75%0Timeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 17,989 shares; 2026Q1: 24,989 shares; 2026Q2: 24,989 shares 24,989$3.85M0.73%0Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 41,100 shares; 2025Q3: 56,600 shares; 2025Q4: 137,800 shares; 2026Q1: 137,800 shares; 2026Q2: 137,800 shares 137,800$3.72M0.71%0Timeline
PROKPROKIDNEY CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,838,411 shares; 2026Q1: 1,806,939 shares; 2026Q2: 1,806,939 shares 1,806,939$3.69M0.7%0Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 102,900 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 20,900 shares; 2026Q2: 72,100 shares 72,100$3.66M0.7%+51,200Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 7,380 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 33,400 shares 33,400$3.18M0.6%newTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 124,440 shares; 2024Q4: 293,851 shares; 2025Q1: 333,851 shares; 2025Q2: 22,951 shares; 2025Q3: 22,951 shares; 2025Q4: 22,951 shares; 2026Q1: 22,931 shares; 2026Q2: 22,951 shares 22,951$2.81M0.53%+20Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 5,000 shares; 2025Q2: 5,000 shares; 2025Q3: 5,000 shares; 2025Q4: 5,000 shares; 2026Q1: 5,000 shares; 2026Q2: 5,000 shares 5,000$2.71M0.52%0Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 33,407 shares; 2026Q1: 38,407 shares; 2026Q2: 38,407 shares 38,407$2.7M0.51%0Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 29,200 shares; 2025Q3: 29,200 shares; 2025Q4: 29,200 shares; 2026Q1: 29,200 shares; 2026Q2: 29,200 shares 29,200$1.87M0.35%0Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 383,200 shares 383,200$839K0.16%newTimeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,500 shares; 2026Q1: 2,500 shares; 2026Q2: 2,500 shares 2,500$837K0.16%0Timeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 17,019 shares; 2026Q1: 17,019 shares; 2026Q2: 17,019 shares 17,019$663K0.13%0Timeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 42,080 shares; 2026Q1: 42,080 shares; 2026Q2: 42,080 shares 42,080$612K0.12%0Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 15,437 shares; 2024Q4: 204,045 shares; 2025Q1: 90,745 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 8,100 shares; 2026Q1: 4,900 shares; 2026Q2: 4,900 shares 4,900$605K0.12%0Timeline
PEPGPEPGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 205,324 shares; 2026Q1: 205,324 shares; 2026Q2: 205,324 shares 205,324$370K0.07%0Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,000 shares 4,000$355K0.07%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
XBISPDR SERIES TRUST S&P BIOTECHput100,000$15.8Mnew

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
INSMINSMED INC279,700$45.7Mput
LLYELI LILLY & CO38,220$35.2Mshares
MRNAMODERNA INC200,000$10.2Mcall
TERNTERNS PHARMACEUTICALS INC104,800$5.53Mshares
ASNDASCENDIS PHARMA A/S17,740$4.06Mshares
ABBVABBVIE INC14,500$3.15Mshares
SLNOSOLENO THERAPEUTICS INC68,490$2.29Mshares
BBIOBRIDGEBIO PHARMA INC20,400$1.51Mshares
APGEAPOGEE THERAPEUTICS INC5,886$495Kshares
AVTXAVALO THERAPEUTICS INC28,970$433Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001937964-26-000008 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001937964-26-000008 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001937964-26-000007 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001937964-26-000002 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR/A 0001937964-25-000009 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001937964-25-000008 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001937964-25-000006 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001937964-25-000004 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001937964-25-000003 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001937964-24-000006 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001937964-24-000005 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001937964-24-000004 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001937964-24-000001 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001937964-23-000006 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001937964-23-000005 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001937964-23-000004 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001420506-23-000693 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set